Cardiol Therapeutics Inc. (TSX:CRDL)

Canada · Delayed Price · Currency is CAD

1.490

-0.010 (-0.67%)

Apr 25, 2025, 4:00 PM EDT

Cardiol Therapeutics Employees

Cardiol Therapeutics had 18 employees as of December 31, 2024. The number of employees increased by 12 or 200.00% compared to the previous year.

Employees

18

Change

12

Growth

200.00%

Revenue / Employee

n/a

Profits / Employee

-2.04M CAD

Market Cap

123.09M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	18	12	200.00%
Dec 31, 2018	6	-	-

Related Stocks

Company Name	Employees
Green Thumb Industries	4,800
dentalcorp Holdings	10,200
Sienna Senior Living	12,263
Extendicare	23,000
Trulieve Cannabis	6,000
WELL Health Technologies	1,507
Cronos Group	459
Curaleaf Holdings	5,519

Employee Rankings

Cardiol Therapeutics News

9 days ago - Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Newsfile Corp
24 days ago - Cardiol Therapeutics Announces Year-End 2024 Update on Operations - Newsfile Corp
7 weeks ago - Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - Newsfile Corp
2 months ago - Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure - Newsfile Corp
2 months ago - Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts - Seeking Alpha
2 months ago - Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Newsfile Corp
4 months ago - PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis - GlobeNewsWire
5 months ago - CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study - Benzinga